176 related articles for article (PubMed ID: 28375712)
1. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
Ayyildiz D; Gov E; Sinha R; Arga KY
OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
[TBL] [Abstract][Full Text] [Related]
2. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
3. Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer.
Gov E; Kori M; Arga KY
OMICS; 2017 Oct; 21(10):603-615. PubMed ID: 28937943
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
Li Y; Sahni N; Yi S
Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.
Zhao L; Li Y; Zhang Z; Zou J; Li J; Wei R; Guo Q; Zhu X; Chu C; Fu X; Yue J; Li X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33135729
[TBL] [Abstract][Full Text] [Related]
7. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
8. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
9. Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.
Martínez-Canales S; López de Rodas M; Nuncia-Cantarero M; Páez R; Amir E; Győrffy B; Pandiella A; Galán-Moya EM; Ocaña A
Cancer Med; 2018 May; 7(5):1896-1907. PubMed ID: 29575713
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer mapping of differential protein-protein interactions.
Gulfidan G; Turanli B; Beklen H; Sinha R; Arga KY
Sci Rep; 2020 Feb; 10(1):3272. PubMed ID: 32094374
[TBL] [Abstract][Full Text] [Related]
11. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
Vathipadiekal V; Wang V; Wei W; Waldron L; Drapkin R; Gillette M; Skates S; Birrer M
Clin Cancer Res; 2015 Nov; 21(21):4960-9. PubMed ID: 25944803
[TBL] [Abstract][Full Text] [Related]
12. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
[TBL] [Abstract][Full Text] [Related]
13. Discover the molecular biomarker associated with cell death and extracellular matrix module in ovarian cancer.
Liu Q; Guo J; Cui J; Wang J; Yi P
Biomed Res Int; 2015; 2015():735689. PubMed ID: 25861644
[TBL] [Abstract][Full Text] [Related]
14. Molecular signatures of ovarian diseases: Insights from network medicine perspective.
Kori M; Gov E; Arga KY
Syst Biol Reprod Med; 2016 Aug; 62(4):266-82. PubMed ID: 27341345
[TBL] [Abstract][Full Text] [Related]
15. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer.
Gov E; Arga KY
Sci Rep; 2017 Jul; 7(1):4996. PubMed ID: 28694494
[TBL] [Abstract][Full Text] [Related]
16. Pathway crosstalk analysis based on protein-protein network analysis in ovarian cancer.
Pan XH
Asian Pac J Cancer Prev; 2012; 13(8):3905-9. PubMed ID: 23098491
[TBL] [Abstract][Full Text] [Related]
17. Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways.
Karagoz K; Sinha R; Arga KY
OMICS; 2015 Feb; 19(2):115-30. PubMed ID: 25611337
[TBL] [Abstract][Full Text] [Related]
18. Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path method.
Shen S; Gui T; Ma C
Oncotarget; 2017 Jun; 8(25):41432-41439. PubMed ID: 28611293
[TBL] [Abstract][Full Text] [Related]
19. Detection of driver protein complexes in breast cancer metastasis by large-scale transcriptome-interactome integration.
Garcia M; Finetti P; Bertucci F; Birnbaum D; Bidaut G
Methods Mol Biol; 2014; 1101():67-85. PubMed ID: 24233778
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.
Faratian D; Zweemer AJ; Nagumo Y; Sims AH; Muir M; Dodds M; Mullen P; Um I; Kay C; Hasmann M; Harrison DJ; Langdon SP
Clin Cancer Res; 2011 Jul; 17(13):4451-61. PubMed ID: 21571868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
